World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12605000308695
Date of registration: 06/09/2005
Prospective Registration: No
Primary sponsor: MediClin Pty Ltd
Public title: Perioperative ischaemic evaluation trial
Scientific title: The effect of perioperative metoprolol on cardiac morbidity and mortality in patients presenting for non-cardiac surgery
Date of first enrolment: 31/01/2003
Target sample size: 10000
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12605000308695.aspx
Study type:  Interventional
Study design:  Purpose: Prevention; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy;  
Phase:  Phase 3 / Phase 4
Countries of recruitment
Australia
Contacts
Name: Prof Associate Professor Kate Leslie   
Address:  Department of Anaesthesia and Pain Management Royal Melbourne Hospital Parkville VIC 3050 Australia
Telephone: +61 3 93427000
Email: kate.leslie@mh.org.au
Affiliation: 
Name: Prof Associate Professor Kate Leslie   
Address:  Department of Anaesthesia and Pain Management Royal Melbourne Hospital Parkville VIC 3050 Australia
Telephone: +61 3 93427000
Email: kate.leslie@mh.org.au
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: With or at risk of ischaemic heart disease. Having moderatie or high risk non-cardiac surgery.
Exclusion criteria: Bradycardia or heart block, bronchospasm, recent CABG surgery, beta-blockers or verapamil.

Age minimum: 45 Years
Age maximum: Not stated
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Surgery - Other surgery
Perioperative cardiac morbidity and mortality within 30 days of surgery;
Perioperative cardiac morbidity and mortality within 30 days of surgery
Intervention(s)
Metoprolol CR 200 mg daily for 30 days.
Primary Outcome(s)
Perioperative cardiac morbidity[30 days after surgery]
Perioperative cardiac mortality[30 days after surgery]
Secondary Outcome(s)
Safety outcomes[Within 30 days of surgery.]
Secondary ID(s)
Nil known
Source(s) of Monetary Support
AstraZeneca
NHMRC
CIHR
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Alfred
Status: Not approved
Approval date:
Contact:
Auckland City
Status: Not approved
Approval date:
Contact:
Austin
Status: Not approved
Approval date:
Contact:
Box Hill
Status: Not approved
Approval date:
Contact:
Burnie
Status: Not approved
Approval date:
Contact:
Geelong Hospital
Status: Not approved
Approval date:
Contact:
John Hunter
Status: Not approved
Approval date:
Contact:
Kuala Lumpur
Status: Not approved
Approval date:
Contact:
Manukau
Status: Not approved
Approval date:
Contact:
Middlemore
Status: Not approved
Approval date:
Contact:
Penang
Status: Not approved
Approval date:
Contact:
Prince of Wales, Hong Kong
Status: Not approved
Approval date:
Contact:
Prince of Wales, Sydney
Status: Not approved
Approval date:
Contact:
Royal Melbourne
Status: Not approved
Approval date:
Contact:
Royal North Shore
Status: Not approved
Approval date:
Contact:
Royal Perth
Status: Not approved
Approval date:
Contact:
Royal Prince Alfred
Status: Not approved
Approval date:
Contact:
University Hospital Singapore
Status: Not approved
Approval date:
Contact:
Warringal Hospital
Status: Not approved
Approval date:
Contact:
Western
Status: Not approved
Approval date:
Contact:
Westmead
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history